András Strassz

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

Nancy L. Bartlett, Alex F. Herrera, Eva Domingo‐Doménech et al. · Blood · 2020 · 145 citations · Full text

Inhibition of phosphoglucomutase activity by lithium alters cellular calcium homeostasis and signaling in <i>Saccharomyces cerevisiae</i>

Péter Csutora, András Strassz, Ferenc Boldizsár et al. · American Journal of Physiology-Cell Physiology · 2005 · 31 citations

A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

Nancy L. Bartlett, Robert W. Chen, Eva Domingo‐Doménech et al. · Blood · 2018 · 16 citations

A First in Human Study Planned to Evaluate Hdp-101, an Anti-BCMA Amanitin Antibody-Drug Conjugate with a New Payload and a New Mode of Action, in Multiple Myeloma

András Strassz, Marc S. Raab, Robert Z. Orlowski et al. · Blood · 2020 · 12 citations

INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE

Stephen M. Ansell, Nancy L. Bartlett, R.W. Chen et al. · Hematological Oncology · 2019 · 10 citations